Assessing whether low- or high-dose aspirin is better for patients with coronary artery disease will be the focus of the first clinical trial to be conducted through PCORnet, the National Patient-Centered Clinical Research Network.
The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors approved the trial topic and up to $10 million to fund the study.
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access